Ashwagandha (Withania somnifera): Adaptogenic Stress Response, Cortisol, and Hormonal Balance — Evidence vs. the Hype Machine

Ashwagandha (Withania somnifera): Adaptogenic Stress Response, Cortisol, and Hormonal Balance — Evidence vs. the Hype Machine

Ashwagandha has become the darling of the supplement industry’s adaptogen category, appearing in everything from stress-relief gummies to testosterone boosters to sleep formulas. Marketed as a cure-all for modern stress, ashwagandha is one of the few herbal ingredients that actually has a growing body of clinical trial data behind it — though the quality and scope of that data is considerably narrower than supplement advertising suggests.

Tutela Medical evaluated the peer-reviewed evidence, examined dosing practices across commercial products, and separated what ashwagandha may legitimately do from what the marketing claims it does.

What Is Ashwagandha?

Withania somnifera is a nightshade family shrub native to India and North Africa, used in Ayurvedic medicine for over 3,000 years. Its bioactive compounds — primarily withanolides (steroidal lactones), withaferin A, and sitoindosides — are concentrated in the root and, to a lesser extent, the leaves. Modern standardized extracts focus on withanolide concentration, with KSM-66 (standardized to 5% withanolides, root-only extract) and Sensoril (standardized to 10% withanolides, root and leaf extract) being the two most-studied branded forms.

The distinction between root-only and root-plus-leaf extracts matters because withaferin A, concentrated in leaves, has demonstrated cytotoxic properties in cell studies. Whether leaf-containing extracts present a safety concern at supplemental doses remains debated, but Tutela Medical notes that most safety data comes from root-only extracts.

Evidence Evaluation

What Tutela Medical Finds Credible — and What It Does Not

The stress and cortisol data is the strongest case for ashwagandha, and Tutela Medical finds it reasonably credible with important caveats. Multiple randomized controlled trials have shown statistically significant reductions in perceived stress scores and serum cortisol levels compared to placebo. A 2021 systematic review identified 12 RCTs with generally positive outcomes for anxiety and stress. However:

• Most trials are small (30–100 participants), short (8–12 weeks), and many are funded by extract manufacturers (KSM-66’s parent company Ixoreal Biomed has funded multiple studies)
• The magnitude of effect is modest — cortisol reductions of 14–28% sound impressive until you consider that cortisol fluctuates by 50%+ throughout a normal day
• No trial has compared ashwagandha to established anxiolytic therapies (SSRIs, CBT) for clinical anxiety disorders
• Long-term safety data beyond 12 weeks is sparse

The testosterone claims are where Tutela Medical sees the most consumer exploitation. The frequently cited Lopresti et al. (2019) study showed a ~15% increase in testosterone in overweight men aged 40–70 over 16 weeks. This is a single small trial in a specific population. Extrapolating this to “ashwagandha boosts testosterone” for young, healthy men is scientifically irresponsible — and precisely what most supplement companies do.

Hepatotoxicity Concerns: The Safety Signal Most Brands Ignore

The National Institutes of Health LiverTox database documented multiple case reports of ashwagandha-associated liver injury, leading to an updated safety assessment. Iceland and other European countries have investigated ashwagandha liver safety signals. While causality is difficult to establish definitively, the signal is strong enough that Tutela Medical considers it irresponsible for any ashwagandha product to omit liver safety warnings.

Risk factors that may increase hepatotoxicity susceptibility include concurrent use of other hepatotoxic supplements or medications, pre-existing liver conditions, and high-dose or prolonged use.

Drug Interactions

• Thyroid medications (levothyroxine): Ashwagandha may increase thyroid hormone levels. Patients with thyroid disorders should not use ashwagandha without endocrinologist supervision.
• Immunosuppressants: Ashwagandha may stimulate immune activity, potentially counteracting immunosuppressive therapy.
• Sedatives / benzodiazepines: May potentiate sedative effects due to GABAergic activity.
• Blood sugar-lowering medications: May enhance hypoglycemic effects. Monitor blood glucose closely.
• Blood pressure medications: May have additive blood pressure-lowering effects.

Who May Reasonably Consider Ashwagandha

• Adults experiencing chronic, non-clinical stress who prefer a non-pharmaceutical approach (as a complement to lifestyle interventions, not a replacement for therapy)
• Individuals with poor sleep quality potentially related to elevated stress/cortisol
• People who have discussed it with their healthcare provider and have no contraindications

Who Should Avoid Ashwagandha

• Individuals with thyroid disorders (particularly hyperthyroidism) — ashwagandha can alter thyroid hormone levels
• Pregnant or breastfeeding women (traditionally contraindicated; insufficient safety data)
• People with autoimmune conditions (potential immune stimulation)
• Anyone with liver disease or taking hepatotoxic medications
• Nightshade-sensitive individuals (ashwagandha is in the Solanaceae family)
• People expecting dramatic testosterone or cognitive enhancement from a supplement alone

Tutela Medical’s Verdict

Ashwagandha occupies a relatively unusual position in the supplement world: it has more clinical trial support than most herbal ingredients, but that support is still modest in scale and narrower in scope than the industry pretends. The stress and cortisol data is the most convincing and the most relevant to how most people use the supplement. Everything else — testosterone boosting, cognitive enhancement, athletic performance — is built on preliminary data that the marketing has dramatically outpaced.

If you choose to try ashwagandha, use a standardized branded extract (KSM-66 or Sensoril) at studied doses (300–600 mg/day), limit use to 8–12 weeks initially, monitor for any signs of liver distress, and maintain realistic expectations. It is a modest adaptogen, not a miracle compound.

For more evidence-based supplement analysis, explore our Supplement Reviews section. Related topics are covered in our Male Enhancement and Brain Health categories.

*These statements have not been evaluated by the Food and Drug Administration. Supplements discussed are not intended to diagnose, treat, cure, or prevent any disease. Consult a qualified healthcare provider before starting any supplement regimen.

TutelaMedical.com is an independent health research publication. Our content reflects independent analysis and does not constitute medical advice.